Claire Danberg
Subscribe to Claire Danberg's PostsClaire E. Danberg focuses her practice on antitrust matters and competition law, including antitrust litigation and compliance matters, as well as consumer protection. Claire focuses her work across a variety of industries, including healthcare, consumer products and technology and manufacturing. In addition to her antitrust and litigation work, Claire maintains an active pro bono practice. Read Claire Danberg's full bio.
Heard at the 2025 Antitrust Law Section Spring Meeting
By Lisa P. Rumin, Reese Poncia, Anthony S. Ferrara, Elai Katz, Megan Ingram, Royce Brosseau, Claire Danberg, Betty Zhang and Alex Grayson on Apr 10, 2025
Posted In Cartel Enforcement, Consumer Protection/Privacy, DOJ Developments, EC Developments, FTC Developments, Healthcare Antitrust, Mergers & Acquisitions
The American Bar Association Antitrust Law Section held its annual Spring Meeting from April 2 to 5 in Washington, DC, where federal, state, and international antitrust enforcers shared key updates and enforcement priorities. At the Spring Meeting, antitrust agencies signaled continued scrutiny of mergers, noncompete agreements, and Big Tech – plus an uptick in state-level...
Continue Reading
Heard at the 2024 Antitrust Law Section Spring Meeting: Part I
By Gregory E. Heltzer, Lisa P. Rumin, Reese Poncia, Anthony S. Ferrara, Claire Danberg, Glenna Siegel, Bailey K. Sanders, Betty Zhang and Alex Grayson on Apr 11, 2024
Posted In DOJ Developments, FTC Developments, Healthcare Antitrust, Mergers & Acquisitions, Monopolization/Abuse of Dominance
The American Bar Association Antitrust Law Section’s annual Spring Meeting is underway in Washington, DC. The annual Spring Meeting features updates from federal, state and international antitrust enforcers and extensive discussion on priority antitrust issues affecting various industries. In this article, we highlight the key takeaways from the first portion of the Spring Meeting. Read...
Continue Reading
Antitrust M&A Snapshot | Q4 2023
By Claire Danberg, Emilia Bonine, Jon B. Dubrow, Joel R. Grosberg, Stéphane Dionnet, Matt Evola and Max Küttner on Feb 14, 2024
Posted In DOJ Developments, EC Developments, EU Developments, FTC Developments, Healthcare Antitrust, Mergers & Acquisitions
Topics covered in this edition: New Merger Guidelines Released FTC Focused on Pharmaceutical Companies FTC Targets “Moat-Building” Mergers Fifth Circuit Fuels FTC’s Vertical Mergers Agenda FTC Losing Streak Reverses During the Fourth Quarter Ex post Review in the Merger Control Sphere Occurring More and More Frequently Access the full issue.
Continue Reading
Heard at the 2023 Spring Meeting: Part 2
By Gregory E. Heltzer, Lisa P. Rumin, Reese Poncia, Joshua W. Eastby, Graham Hyman, Claire Danberg, Bailey K. Sanders, William Paige and Glenna Siegel on Apr 5, 2023
Posted In Consumer Protection/Privacy, DOJ Developments, FTC Developments, Healthcare Antitrust, Mergers & Acquisitions, Monopolization/Abuse of Dominance
The American Bar Association’s Antitrust Law Section held its annual Spring Meeting in Washington, DC, on March 29–31, 2023. The Spring Meeting sessions featured updates from federal, state, and international antitrust enforcers and thought-invoking discussions on leading antitrust issues facing the business community today. Following Part 1, this post summarizes key takeaways from the second...
Continue Reading
Heard at the 2023 Spring Meeting: Part 1
By Gregory E. Heltzer, Lisa P. Rumin, Reese Poncia, Joshua W. Eastby, Glenna Siegel, Bailey K. Sanders, Claire Danberg, Graham Hyman and William Paige on Apr 3, 2023
Posted In DOJ Developments, FTC Developments, Healthcare Antitrust, Mergers & Acquisitions, Monopolization/Abuse of Dominance
The American Bar Association’s Antitrust Law Section recently held its annual Spring Meeting in Washington, DC, featuring updates from federal, state, and international antitrust enforcers and in-depth commentary on leading antitrust issues facing the business community today. This post recaps key takeaways from the first portion of the Spring Meeting. CIVIL ENFORCEMENT AND MERGER REVIEW:...
Continue Reading
Antitrust M&A Snapshot | Q2 2022
By Claire Danberg, Karolien Van der Putten, Jon B. Dubrow, Joel R. Grosberg, Lisa P. Rumin and Hendrik Viaene on Sep 26, 2022
Posted In Consumer Protection/Privacy, DOJ Developments, EC Developments, EU Developments, FTC Developments, Healthcare Antitrust, Mergers & Acquisitions, Monopolization/Abuse of Dominance
In the United States, parties continue to be cautious in litigating challenged transactions. Since January 2021, the US Federal Trade Commission (FTC) and Department of Justice (DOJ) filed lawsuits (or threatened to sue) to block 16 transactions. Of those transactions, 12 were abandoned and six are in various stages of litigation. The data suggest that...
Continue Reading
Heard on Day Two and Three of 2022 Antitrust Law Spring Meeting
By Lisa P. Rumin, Han Cui, Claire Danberg, Anthony S. Ferrara, Graham Hyman and Zachary Sproull on Apr 12, 2022
Posted In Cartel Enforcement, Consumer Protection/Privacy, DOJ Developments, FTC Developments, Healthcare Antitrust, Joint Ventures/Competitor Collaboration, Mergers & Acquisitions, Monopolization/Abuse of Dominance
On April 7 and 8, 2022, the American Bar Association’s Antitrust Law Section wrapped up its annual Spring Meeting. The event featured updates and remarks from several antitrust enforcers, including FTC Chair Lina Khan and US Assistant Attorney General for the Antitrust Division Jonathan Kanter. In this post, we share key takeaways from the final...
Continue Reading
DOJ Antitrust Division Signals Impending Criminal Monopolization Cases
By Andrew Lee, Katharine M. O'Connor, Justin P. Murphy, Paul M. Thompson and Claire Danberg on Mar 11, 2022
Posted In Cartel Enforcement, DOJ Developments, FTC Developments, Monopolization/Abuse of Dominance
WHAT HAPPENED On March 2, 2022, the US Department of Justice (DOJ) Antitrust Division Deputy Assistant Attorney General Richard Powers revealed that the DOJ intends to investigate and pursue alleged criminal violations against individuals or companies who violate Section 2 of the Sherman Act. For more than 40 years, criminal enforcement of antitrust laws have...
Continue Reading
